If regulatory submissions proceed as expected, the earliest plausible timeline for a market authorisation decision in the UK or Europe would be 2026 or 2027 though this is subject to the pace of regulatory review, the completeness of the submission package, and any additional data requests from the MHRA or EMA
Its price is influenced by various factors, such as production costs, research and development expenses, market demand, etc
Urology 81 (6), 1379.e13711378
Glioma, melatonin, and radiotherapy [PMID: 16778225] Laboratory literature summary: Glioma, melatonin, and radiotherapy
Patients most often raise this combination in the context of slower recovery after training, sleep that no longer feels restorative, and body composition that has stopped responding to the same effort that used to work